Capstone (CAPS) Stock Price, News & Analysis

Company Overview

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC.

Key Stats

• Today's Range: $1.58 to $1.77
• 50-Day Range: $1.70 to $3.90
• 52-Week Range: $1.58 to $16.18
• Volume: 5,638 shs
• Average Volume: 401,592 shs
• Market Capitalization: $276,500.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CAPS Stock Analysis - Frequently Asked Questions

How have CAPS shares performed this year?

Capstone's stock was trading at $2.24 at the beginning of the year. Since then, CAPS shares have decreased by 21.9% and is now trading at $1.75.
View the best growth stocks for 2025 here.

How were Capstone's earnings last quarter?

Capstone Holding Corp. (OTCMKTS:CAPS) posted its earnings results on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter. The biotechnology company earned $2 million during the quarter.

When did the company's quiet period expire?

Capstone's quiet period expired on Tuesday, April 15th. Capstone had issued 1,250,000 shares in its public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During the company's quiet period, insiders and underwriters that worked on the IPO were restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Capstone?

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Capstone own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Capstone investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

• Last Earnings: 8/13/2018
• Today: 5/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CAPS
• CIK: 887151
• Web: www.capstonethx.com
• Phone: (708) 371-0660
• Fax: 602-286-5300
• Employees: 38
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $44.88 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 158,000
• Free Float: 90,000
• Market Cap: $276,500.00
• Optionable: Not Optionable
• Beta: -0.82